Surgeons' preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ.
Claudia J C MeursJanine Astrid van TilMarian B E Menke-PluijmersStefanie de VetSabine SieslingPieter J WestenendPublished in: PloS one (2022)
The inter-hospital variation in the use of SLNB could not be attributed to organisational factors or surgeons' preferences for risk factors. The risk factors that most surgeons reported as reasons for performing SLNB are consistent with the factors described in the Dutch treatment guideline for the use of SLNB.